Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
Shortened Course of Radiation Therapy After Trans-oral Robotic Surgery in Patients With HPV-Mediated Oropharyngeal Squamous Cell Carcinoma.
for
Oropharyngeal Squamous Cell Carcinoma,
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: All
Age: 18+
Code: NCT07044635
Phase2, Recruiting
Interested in new gene therapy trials?
Get alerts for new trials in your area by subscribing now
Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas
for
Basal Cell Carcinoma (BCC)
Location: Phoenix AZ
Sponsor: Nathalie Zeitouni
Sex: All
Age: 18+
Code: NCT06623201
Phase1, Recruiting
Adapting Rehabilitation Delivery for Maximum Impact at Home-2 (ReDI-2)
for
Knee Osteoarthritis, Hip Osteoarthritis
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 0+
Code: NCT07055113
Recruiting
A Study of Oral Tetrahydrouridine-Decitabine in Relapsed or Refractory Myelodysplastic Syndromes (MDS)
for
MDS
Location: The Bronx NY
Sponsor: Treebough Therapies
Sex: All
Age: 18+
Code: NCT07006025
Phase1, Recruiting
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Damariscotta ME, Bath ME, Augusta ME, Brunswick ME,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06992427
Phase3, Recruiting
Phase 2 Pragmatic Trial of Sentinel Lymph Node Biopsy (SLNB) in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck
for
Cutaneous Squamous Cell Carcinoma of the Head and Neck,
Location: Sacramento CA
Sponsor: University of California, Davis
Sex: All
Age: 18+
Code: NCT06990737
Phase2, Recruiting
G-CSF After Chemo-radiation in Patients With Glioblastoma
for
MGMT-Methylated Glioblastoma, Glioblastoma (GBM),
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT06649851
Phase2, Recruiting
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
for
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy,
Location: El Paso TX, Murray UT, Los Angeles CA
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT07226986
Phase1, Phase2, Recruiting
HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission
for
Breast Cancer, HER2-positive Breast Cancer,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT07459673
Phase2, Recruiting
Evaluation of Pain Management After Surgery When Using Exparel in the Pediatric Population
Sponsor: Texas Scottish Rite Hospital for Children
Sex: All
Age: 13 - 21
Code: NCT06559215
Phase2, Recruiting
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Location: Boston MA, Newton MA, Commack NY, Uniondale NY,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07227415
Phase1, Phase2, Recruiting
NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma
for
Large B-cell Lymphoma
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT07052305
Phase1, Recruiting
Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)
for
Relapsed / Refractory Osteosarcoma
Location: Boston MA, Los Angeles CA
Sponsor: Lantheus Medical Imaging
Sex: All
Age: 12+
Code: NCT07357519
Phase1, Phase2, Recruiting
Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL
for
B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia
Location: Charleston SC
Sponsor: Medical University of South Carolina
Sex: All
Age: 18+
Code: NCT05702853
Phase1, Phase2, Recruiting
CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies
for
Recurrent B-Cell Non-Hodgkin Lymphoma,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT04892277
Phase1, Recruiting
Dextenza in the Post-op Management of Vitreoretinal Surgeries